The cocaine-and amphetamine-regulated transcript (CART) peptide is a recently characterized neuropeptide implicated in the control of appetite. We hypothesized that genetic variation in CART may contribute to human obesity. The entire coding region of CART was determined by nucleotide sequencing in 91 unrelated subjects with severe early-onset obesity. A novel amino acid change, Ser66Thr, was found in 2 probands and in 0 of 100 control subjects but did not cosegregate with obesity in family studies. Two common polymorphisms were found in the 3-untranslated region (A1475G and ⌬A1457). An effect of these polymorphisms on body composition and intermediate phenotypes related to obesity was examined in a large Caucasian population in the U.K. Neither polymorphism showed any significant relationship with obesity; however, men heterozygous for the A1475G variant had significantly lower waist-to-hip ratio (WHR), fasting plasma insulin, and fasting triglycerides. Regression analysis indicated that the effects on insulin and triglycerides were likely to be secondary to the effects on WHR. Thus, we have conducted the first systematic study of the CART gene in human obesity, and although no clear association with obesity was found, the data suggest that genetic variation in the CART locus might influence fat distribution and variables related to syndrome X. Diabetes 49:872-875, 2000
D
ata from twin, adoption, and family studies indicate that genetic factors play a major role in the determination of the interindividual variation in fat mass within human populations (1, 2) . Until recently, however, little precise information regarding genetic causes of human obesity has been available. In the past 3 years, 5 monogenic defects causing human morbid obesity have been identified, namely, mutations in the genes encoding leptin (3, 4) , leptin receptor (5), prohormone convertase (PC)-1 (6), pro-opiomelanocortin (POMC) (7) , and the melanocortin-4 receptor (MC4R) (8, 9) . In all of these syndromes, hyperphagia results from dysfunction of hypothalamic pathways controlling satiety. Genetic defects in these molecules are responsible for only a small fraction of human morbid obesity, and it is likely that the detailed elucidation of the molecular mechanisms of appetite control will provide further candidate genes that may be implicated in human obesity. One such molecule is cocaine-and amphetamine-regulated transcript (CART), a recently discovered hypothalamic neuropeptide (10) .
CART was originally identified by polymerase chain reaction (PCR) differential display as a novel mRNA, the expression of which was induced in rat striatum after acute administration of psychomotor stimulants (10) . Subsequently, CART was found to be one of the most abundant mRNAs in the hypothalamus (11) . Considerable evidence implicates CART in the control of mammalian feeding behavior. CART is highly expressed in the arcuate and paraventricular nuclei of the hypothalamus, areas known to be involved in the control of appetite (10, 12) . CART neurons show fos-immunoreactivity after intravenous injections of leptin in rats (13) , and conversely, hypothalamic CART mRNA levels are decreased in hypoleptinemic states, such as in the ob/ob mouse, and after prolonged fasting. In these conditions, CART expression is restored by leptin administration (14) . Intracerebroventricular injection of recombinant CART into rats and mice inhibits normal and starvation-induced feeding and blocks the feeding response induced by neuropeptide Y (14) . Conversely, after central administration of anti-serum against CART in rats, the feeding response was increased (14) . These data strongly implicate CART as an endogenous satiety factor.
To establish whether genetic defects in CART might contribute to human obesity, we used direct nucleotide sequencing to examine the coding regions of the CART gene in 91 unrelated subjects with severe early-onset obesity. Having detected common sequence variants within CART in this cohort, we have subsequently examined the relationships between these polymorphisms and obesity-related phenotypes in an independent, large, ethnically homogeneous Caucasian population.
We studied 91 severely obese children in whom no evidence for a recognized clinical syndrome or a structural hypothalamic cause for their obesity has been found. The possibility of previously described monogenic defects contributing to the obesities has been excluded through biochemical assays (leptin, PC-1), clinical descriptions (POMC deficiency), and mutational screening (MC4R). In all cases, obesity was manifest before the age of 10 years and BMI was >4 SD above the mean for their age. The human CART gene is encoded in a 2.5-kb segment of genomic DNA on chromosome 5 (15) . The 900-nucleotide CART transcript is contained within 3 exons and encodes a mature peptide 89 amino acids in length (15) . A 1.5-kb amplicon, including the entire coding sequence of CART and all intron/exon boundaries, was amplified by PCR. To determine the nucleotide sequence of CART, sequencing primers were designed from intronic sequence flanking the 3 exons, thus allowing the entire coding region, including all intron/exon boundaries, to be sequenced.
One subject was found to be heterozygous for a missense amino acid substitution, Ser66Thr, in exon 2 of CART (GenBank accession number U20325). Although little information is as yet available on the structure/function relationships in CART, serine is conserved in this position in the human and rat sequences. The proband was a Caucasian female from a nonconsanguineous family who was first noted to be severely obese at age 4 and currently weighs 95 kg at age 14 years. Of 11 other family members available for study, 4 had a history of early-onset obesity and 7 were nonobese. The mutation did not clearly cosegregate with the obese phenotype, with 3 of 4 obese and 3 of 7 nonobese relatives being carriers of the mutation (data not shown). The same variant (Ser66Thr) was found in another severely obese subject and also in his lean father. The variant was not detected in 100 unrelated adult Caucasian control subjects.
In addition to the rare missense mutation, 2 common single nucleotide polymorphisms were identified within the 3Ј-untranslated region (3Ј-UTR) of exon 3. A heterozygous variant (A1475G) occurring 39 base pairs 3Ј from the stop codon was found in 18 (19.8%) subjects. A second variant was also found, involving the deletion of an adenine at position 1457 (⌬A1457), 21 nucleotides 3Ј from the stop codon. For the ⌬A1457 variant, among the 91 morbidly obese subjects, 80 (87.9%) were wild-type, 10 (11.0%) were heterozygous, and 1 (1.1%) was homozygous. It is possible that these common variants in the 3Ј-UTR might have an influence on CART expression, either directly through influences on mRNA stability or indirectly through linkage disequilibrium with other functional variants in or near the CART gene. We therefore examined the association between these variants and obesityrelated phenotypes in a large, ethnically homogenous, wellcharacterized Caucasian population.
The Isle of Ely Study (16, 17) is a prospective populationbased cohort study of the etiology and pathogenesis of type 2 diabetes and related metabolic disorders. Anthropometric and biochemical data were available in this study both at baseline and after a 4.5-year follow-up period. Subjects, all Caucasians from the U.K., were aged between 40 and 65 years at baseline. Responses for successive time periods were analyzed with repeated measures design using the Statistical Analysis System procedure MIXED for unbalanced repeated data, with and without adjustment (for age or waistto-hip ratio [WHR]). We examined 412 subjects for the ⌬A1457 variant using direct sequencing and 811 for the A1475G variant using a combination of direct sequencing and mutagenically separated PCR (MS-PCR). In the latter technique, mutagenic bases are incorporated within primer sequences to deliberately introduce additional differences into the allelic PCR products and prevent cross-reactions in subsequent cycles. This selective mutagenesis separates the amplification reactions, allowing for allele-specific screening to occur in the same reaction.
Allele frequencies of the A1475G and ⌬A1457 polymorphisms in the Isle of Ely cohort were 0.076 and 0.087, respectively. Neither polymorphism deviated significantly from Hardy-Weinberg predictions, and the 2 variants were in linkage disequilibrium (P = 0.0072; n = 406). The relationships between these polymorphisms and obesity-related phenotypes were examined using a mixed model analysis, incorporating phenotypic data from baseline and 4.5-year followup and adjusted for age, with men and women analyzed independently. Phenotypic variables examined were BMI, WHR, fasting plasma glucose, fasting plasma insulin (FPI), fasting triglycerides (FT), and fasting nonesterified fatty acids. Neither variant showed any significant association with BMI in men or women. There were no significant associations between any obesity-associated phenotype and the ⌬A1457 variant in either men or women (data not shown). In contrast, men heterozygous for the A1475G variant had significantly lower WHR, FPI, and FT (Table 1 ). There were no significant gene-age or gene-WHR interactions for any of the responses. Table 1 also shows the results adjusted for WHR, which demonstrate that the effect of the gene on triglycerides and fasting insulin is not independent of WHR, suggesting that the observed univariate effects are likely to be mediated through central obesity. There were no significant associations observed in women (data not shown). Combined analysis of the A1475G and ⌬A1457 polymorphisms did not strengthen or significantly alter the associations found (data not shown).
To our knowledge, this is the first systematic analysis of the CART gene in human obesity. We have identified 3 novel genetic variants, a rare missense mutation (Ser66Thr) and 2 common variants (A1475G, and ⌬A1457), within the 3Ј-UTR of the gene. The amino acid substitution did not clearly cosegregate with obesity in the 2 pedigrees. However, a contributory role of this variant to the severe obesity seen in 3 carriers in the first pedigree cannot be excluded. Neither of the common 3Ј-UTR polymorphisms showed any association with BMI. Of note, however, the A1475G variant was associated with a lower WHR in male A/G heterozygotes. Although the association was seen in men only and was of modest statistical significance, an effect of hypothalamic neuropeptide expression on the manifestation of features of syndrome X is biologically plausible.
Bjorntorp and colleagues (18) (19) (20) have provided a substantive body of epidemiologic and pathophysiologic data suggesting that environmental stress may lead to syndrome X through its effects on hypothalamic-pituitary function, with the output of corticotropin, growth hormone, and gonadotropins all influencing fat distribution and insulin resistance. The anatomic localization of CART in the hypothalamus and its responsiveness to psychomotor stimulants makes it an attractive candidate for involvement in the stress response. Although information on the effects of CART administration on pituitary function is very limited, it is plausible that genetic variants influencing CART expression might influence the metabolic response to environmental stress through effects on the hypothalamic-pituitary axis.
In conclusion, mutations in CART are unlikely to be a major cause of early-onset morbid obesity in Caucasians. In this study, however, the regulatory elements of the CART gene were not screened, and thus pathogenic mutations occurring within regulatory regions cannot be excluded. However, the possibility is raised that inherited variation in the CART gene may influence the development of some metabolic features, a hypothesis that provides a potentially novel link between the central nervous system and syndrome X.
RESEARCH DESIGN AND METHODS
PCR and sequencing. Two primers, CART forward (5Ј-GGG CTC GGG CTC ACT ATA AAA G-3Ј) and CART reverse (5Ј-GGA GGA AGG TGT GGT CCT CTG-3Ј), were used in a PCR reaction to amplify the gene from genomic DNA isolated from whole blood using a QIAamp blood kit (Qiagen, London). PCR was performed using BioTaq (Bioline, London) and carried out under standard conditions. Thirty-five cycles (40 s at 96°C, 40 s at 60°C, and 40 s at 72°C) were performed using a PTC-225 Peltier Thermal Cycler (MJ Research, Watertown, MA). The nucleotide sequence of CART was determined by 6 primers (CART F1, 5Ј-CTC GGG CTC ACT ATA AAA GGT-3Ј; CART F2, 5Ј-TGG AAG TGC GCA CCT GGG CT-3Ј; CART F3, 5Ј-CTG TGA GAC TTG CCT GTT GGG-3Ј; CART R1, 5Ј-GGA AGG TGT GGT CCT CTG GG-3Ј; CART R2, 5Ј-GCT GTG TGT ACG ATT CAA GGC-3Ј; and CART R3, 5Ј-GTG CAA GAG AAG AGA CAA GGC-3Ј) at an annealing temperature of 58°C, to sequence the PCR product on both strands. Sequencing was carried out using BigDye terminator chemistry (Perkin-Elmer, Beaconsfield, U.K.) and electrophoresed on an ABI 377 automated DNA sequencer (Perkin-Elmer, Foster City, CA). Mutagenically separated PCR. To detect the A1475G variant in subjects from the Isle of Ely Study, 3 primers were used, 2 allele-specific mutagenically separated PCR (MS-PCR) primers designed from the same DNA strand (5Ј-GGT GTG GTC CTC TGG GGA ACG T-3Ј and 5Ј-GCC AAA CTC CAG GGA GGA ACC TGT GGT CCT CTG GGG AAA CC-3Ј) (mutagenic and allelic positions are underlined) and 1 primer with a sequence derived from the complementary strand (5Ј-AGC TGT GTG ACT GTC CCG A-3Ј). Forty cycles (30 s at 96°C, 30 s at 57°C, and 30 s at 72°C) were performed. Gel electrophoresis was performed using 4% (wt/vol) agarose gels (Gibco BRL, Paisley, U.K.), and the products were subsequently detected with ethidium bromide under ultraviolet illumination. Data are arithmetic means (95% CI) and *geometric means (95% CI). Significance was determined with mixed model analysis. n, the number of total observations in the 2 visits.
